Jacquet M, Hervouet E, Baudu T, Herfs M, Parratte C, Feugeas JP, Perez V, Reynders C, Ancion M, Vigneron M, Baguet A, Guittaut M, Fraichard A, Despouy G

Biology (Basel). 2021 Sep 24;10(10):

The NMD Pathway Regulates mRNA during the EMT.

Baudu T, Parratte C, Perez V, Ancion M, Millevoi S, Hervouet E, Peigney A, Peixoto P, Overs A, Herfs M, Fraichard A, Guittaut M, Baguet A

Biomedicines. 2021 Sep 23;9(10):

(±)-: Pentatarget-Directed Ligand combining Cholinesterase, Monoamine Oxidase, and Glycogen Synthase Kinase 3β Inhibition with Calcium Channel Antagonism and Antiaggregating Properties for Alzheimer's Disease.

Ismaili L, Monnin J, Etievant A, Arribas RL, Viejo L, Refouvelet B, Soukup O, Janockova J, Hepnarova V, Korabecny J, Kucera T, Jun D, Andrys R, Musilek K, Baguet A, García-Frutos EM, De Simone A, Andrisano V, Bartolini M, de Los Ríos C, Marco-Contelles J, Haffen E

ACS Chem Neurosci. 2021 Apr 2;:

The Exon Junction Complex core factor eIF4A3 is a key regulator of HPV16 gene expression.

Meznad K, Paget-Bailly P, Jacquin E, Peigney A, Aubin F, Guittaut M, Mougin C, Prétet JL, Baguet A

Biosci Rep. 2021 Mar 24;:

DNA demethylation agent 5azadC downregulates HPV16 E6 expression in cervical cancer cell lines independently of TBX2 expression.

Perrard J, Morel A, Meznad K, Paget-Bailly P, Dalstein V, Guenat D, Mourareau C, Clavel C, Fauconnet S, Baguet A, Mougin C, Pretet JL

Oncol Lett. 2020 Jan;19(1):1074-1081

Comparative RNA sequencing reveals that HPV16 E6 abrogates the effect of E6*I on ROS metabolism.

Paget-Bailly P, Meznad K, Bruyère D, Perrard J, Herfs M, Jung AC, Mougin C, Prétet JL, Baguet A

Sci Rep. 2019 Apr 11;9(1):5938

Isolation and characterization of an HLA-DRB1*04-restricted HPV16-E7 T cell receptor for cancer immunotherapy.

Mercier-Letondal P, Marton C, Deschamps M, Ferrand C, Vauchy C, Chenut C, Baguet A, Adotévi O, Borg C, Galaine J, Godet Y

Hum. Gene Ther.. 2018 Aug 23;:

5azadC treatment upregulates miR-375 level and represses HPV16 E6 expression.

Morel A, Baguet A, Perrard J, Demeret C, Jacquin E, Guenat D, Mougin C, Prétet JL

Oncotarget. 2017 May;:

Overexpression of MLN51 triggers P-body disassembly and formation of a new type of RNA granules.

Cougot N, Daguenet E, Baguet A, Cavalier A, Thomas D, Bellaud P, Fautrel A, Godey F, Bertrand E, Tomasetto C, Gillet R

J. Cell. Sci.. 2014 Nov;127(Pt 21):4692-701

Perispeckles are major assembly sites for the exon junction core complex.

Daguenet E, Baguet A, Degot S, Schmidt U, Alpy F, Wendling C, Spiegelhalter C, Kessler P, Rio MC, Le Hir H, Bertrand E, Tomasetto C

Mol Biol Cell. 2012 May;23(9):1765-82

Synthetic analogue of rocaglaol displays a potent and selective cytotoxicity in cancer cells: involvement of apoptosis inducing factor and caspase-12.

Thuaud F, Bernard Y, Turkeri G, Dirr R, Aubert G, Cresteil T, Baguet A, Tomasetto C, Svitkin Y, Sonenberg N, Nebigil CG, Desaubry L

J Med Chem. 2009 Aug 27;52(16):5176-87.

Tumor necrosis factor receptor-associated factor 4 is a dynamic tight junction-related shuttle protein involved in epithelium homeostasis.

Kedinger V, Alpy F, Baguet A, Polette M, Stoll I, Chenard MP, Tomasetto C, Rio MC

PLoS ONE. 2008;3(10):e3518

The exon-junction-complex-component metastatic lymph node 51 functions in stress-granule assembly.

Baguet A, Degot S, Cougot N, Bertrand E, Chenard MP, Wendling C, Kessler P, Le Hir H, Rio MC, Tomasetto C

J Cell Sci. 2007 Aug 15;120(Pt 16):2774-84

Intergenic transcription is not required in Th2 cells to maintain histone acetylation and transcriptional permissiveness at the Il4-Il13 locus.

Baguet A, Sun X, Arroll T, Krumm A, Bix M

J Immunol. 2005 Dec 15;175(12):8146-53.

The exon junction core complex is locked onto RNA by inhibition of eIF4AIII ATPase activity.

Ballut L, Marchadier B, Baguet A, Tomasetto C, Seraphin B, Le Hir H

Nat Struct Mol Biol. 2005 Oct;12(10):861-9

Fiche personne Projets Publications

Retrouvez aussi

Personnes

Equipes

Plateformes

Unités de recherche, établissements

Projets de recherche

Publications scientifiques